In this inspiring keynote, Professor Tim Denison—physicist, engineer, and former Medtronic VP of Research—shares his imaginative and prescient for the way forward for neurotechnology and the worldwide innovation ecosystem driving it. Now based mostly at Oxford as a UK authorities–funded Chair in Emerging Technology, Denison displays on the “rhythms” that form each biology and technological progress, highlighting how engineering, neuroscience, and scientific care should evolve collectively to create significant affected person affect.
He contrasts the stagnation of pharmaceutical innovation with the exponential progress of semiconductor and electronics capabilities, arguing that neurotechnology can complement conventional drugs by making use of “Moore’s Law thinking” to growing smarter, responsive neuromodulation therapies. Denison emphasizes the significance of closed‑loop and predictive methods, impressed by pure rhythms like circadian cycles, to construct gadgets that adapt in actual time and probably reshape lengthy‑time period illness trajectories. The keynote additionally outlines classes realized from giant‑scale translational efforts—together with the NIH BRAIN Initiative, subsequent‑era DBS methods, and world public‑non-public collaboration.
Denison describes how aligned engineering, enterprise fashions, regulation, and scientific workflows are important “missing ingredients” in scaling neurotechnology from lab prototypes to actual‑world affect. He closes by introducing the UK’s new £50 million neurotechnology infrastructure funding, aimed toward accelerating gadget improvement, increasing entry, and enabling future breakthroughs in circumstances from epilepsy to incontinence to neurodegeneration.
00:00 Introduction to Tim Denison
00:31 Career Background & Oxford Appointment
01:27 Rhythms of Life, Rhythms of Innovation
02:35 UK Emerging Technology Chair & Industry‑Building Mission
03:08 Collaborators, Clinical Partners & Global Work
03:44 Early Sci‑Fi Neurotech Concepts (1958 Brain Amplifier)
05:14 Why Neurotechnology Matters: Disease Burden & Under‑Treatment
05:56 Pharma’s E‑Room’s Law vs. Engineering’s Moore’s Law
06:45 Vision: Bioelectronic Medicine & Restoring Physiology
07:56 Lessons from Nature: Bees, Predictive Biology & Circadian Rhythms
09:44 Opportunities for Chronotype‑Driven Neuromodulation
10:25 The “Missing Ingredients” in Translation: Economics, Workflow & Regulation
11:29 Innovation Reality Check: Building What’s Viable
12:24 Technology Lifecycles & the S‑Curve of Neuromodulation
13:58 From Human‑in‑the‑Loop to Closed‑Loop Therapies
16:10 Translational Platforms: PC+S, BRAIN Initiative & Clinical Ecosystem
19:42 Ecosystem 2.0: UK Public–Private Neurotechnology Infrastructure
23:40 Future Vision: Scalable Global Therapies & Long‑Term Impact
From Mayo Clinic to your inbox (free):
https://www.mayoclinic.org/patient-visitor-guide/newsletters
Visit Mayo Clinic:
https://www.mayoclinic.org
Connect with Mayo Clinic:
Facebook: https://www.facebook.com/mayoclinic
Instagram: https://www.instagram.com/mayoclinic
X: https://x.com/MayoClinic
Threads: https://www.threads.net/@mayoclinic
